Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.05 USD 3.96% Market Closed
Market Cap: 193.3m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Wall Street
Price Targets

NKTR Price Targets Summary
Nektar Therapeutics

Wall Street analysts forecast NKTR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NKTR is 4.18 USD with a low forecast of 1.31 USD and a high forecast of 7.35 USD.

Lowest
Price Target
1.31 USD
25% Upside
Average
Price Target
4.18 USD
298% Upside
Highest
Price Target
7.35 USD
600% Upside
Nektar Therapeutics Competitors:
Price Targets
002262
Jiangsu Nhwa Pharmaceutical Co Ltd
26% Upside
2096
Simcere Pharmaceutical Group Ltd
36% Upside
DRREDDY
Dr Reddy's Laboratories Ltd
13% Upside
ELAN
Elanco Animal Health Inc
43% Upside
PFIZER
Pfizer Ltd
23% Upside
BMY
Bristol-Myers Squibb Co
1% Downside
4551
Torii Pharmaceutical Co Ltd
4% Downside

Revenue
Forecast

Revenue Estimate
Nektar Therapeutics

For the last 8 years the compound annual growth rate for Nektar Therapeutics's revenue is -11%. The projected CAGR for the next 3 years is -3%.

-11%
Past Growth
-3%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Nektar Therapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Nektar Therapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NKTR's stock price target?
Price Target
4.18 USD

According to Wall Street analysts, the average 1-year price target for NKTR is 4.18 USD with a low forecast of 1.31 USD and a high forecast of 7.35 USD.

What is Nektar Therapeutics's Revenue forecast?
Projected CAGR
-3%

For the last 8 years the compound annual growth rate for Nektar Therapeutics's revenue is -11%. The projected CAGR for the next 3 years is -3%.

Back to Top